Stem cell therapies for treatment of liver disease

Clara Nicolas, Yujia Wang, Jennifer Luebke-Wheeler, Scott Nyberg

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice.

Original languageEnglish (US)
Article number2
JournalBiomedicines
Volume4
Issue number1
DOIs
StatePublished - Mar 1 2016

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Liver
Liver Diseases
Stem Cells
Liver Transplantation
Artificial Liver
Induced Pluripotent Stem Cells
Liver Regeneration
Acute Liver Failure
Cell Transplantation
Therapeutics
Liver Neoplasms
Liver Cirrhosis
Genetic Therapy
Hepatocytes
Safety
Cell Line
Equipment and Supplies
Gene therapy

Keywords

  • Bioartificial liver
  • Cell therapy
  • Cell transplant
  • Gene correction
  • Induced pluripotent stem cells
  • Liver disease
  • Regenerative medicine
  • Stem cell

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Stem cell therapies for treatment of liver disease. / Nicolas, Clara; Wang, Yujia; Luebke-Wheeler, Jennifer; Nyberg, Scott.

In: Biomedicines, Vol. 4, No. 1, 2, 01.03.2016.

Research output: Contribution to journalReview article

Nicolas, Clara ; Wang, Yujia ; Luebke-Wheeler, Jennifer ; Nyberg, Scott. / Stem cell therapies for treatment of liver disease. In: Biomedicines. 2016 ; Vol. 4, No. 1.
@article{47ca7e20a47e449c87efb9693d7c34e4,
title = "Stem cell therapies for treatment of liver disease",
abstract = "Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice.",
keywords = "Bioartificial liver, Cell therapy, Cell transplant, Gene correction, Induced pluripotent stem cells, Liver disease, Regenerative medicine, Stem cell",
author = "Clara Nicolas and Yujia Wang and Jennifer Luebke-Wheeler and Scott Nyberg",
year = "2016",
month = "3",
day = "1",
doi = "10.3390/biomedicines4010002",
language = "English (US)",
volume = "4",
journal = "Biomedicines",
issn = "2227-9059",
publisher = "MDPI AG",
number = "1",

}

TY - JOUR

T1 - Stem cell therapies for treatment of liver disease

AU - Nicolas, Clara

AU - Wang, Yujia

AU - Luebke-Wheeler, Jennifer

AU - Nyberg, Scott

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice.

AB - Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice.

KW - Bioartificial liver

KW - Cell therapy

KW - Cell transplant

KW - Gene correction

KW - Induced pluripotent stem cells

KW - Liver disease

KW - Regenerative medicine

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=85006829105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006829105&partnerID=8YFLogxK

U2 - 10.3390/biomedicines4010002

DO - 10.3390/biomedicines4010002

M3 - Review article

VL - 4

JO - Biomedicines

JF - Biomedicines

SN - 2227-9059

IS - 1

M1 - 2

ER -